BRM270 targets cancer stem cells and augments chemo‑sensitivity in cancer (Review)

Author:

Chandimali Nisansala1,Koh Hyebin2,Kim Jihwan3,Lee Jaihyung4,Park Yang5,Sun Hu-Nan6,Kwon Taeho7

Affiliation:

1. Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea

2. Department of Functional Genomics, University of Science and Technology, Daejeon 34113, Republic of Korea

3. Korean Convergence Medicine Centre, 100 years Oriental Medical Clinic, Seoul 04783, Republic of Korea

4. Epigenetics Drug Discovery Centre, Haeam Convalescence Hospital, Gyeonggi 12458, Republic of Korea

5. Evidence-based Medicine Centre, Park Yang Ho BRM Institute, Seoul 07163, Republic of Korea

6. College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing 163319, P.R. China

7. Primate Resources Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeonbuk 56216, Republic of Korea

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3